Genelux (GNLX) Cash from Investing Activities (2022 - 2026)

Genelux (GNLX) recorded quarterly Cash from Investing Activities of -$8.5 million in Q1 2026, down 230.09% quarter-over-quarter from $6.6 million in Q4 2025, and down 343.35% on a YoY basis from $3.5 million in Q1 2025.

Genelux (GNLX) Cash from Investing Activities (2022 - 2026) Analysis & Trends

Genelux's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$8.5 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 343.35% year-over-year to -$8.5 million; the TTM figure through Mar 2026 stood at $93000.0 (up 103.17% YoY), while the FY2025 annual figure was $12.1 million, up 249.32% from the prior year.
  • Cash from Investing Activities was -$8.5 million for Q1 2026 at Genelux, down from $6.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $6.7 million in Q4 2024 to a low of -$17.1 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$1.4 million across 5 years, with a median of -$193000.0 in 2023.
  • Biggest YoY gain for Cash from Investing Activities was 1541.16% in 2024; the steepest drop was 4219.7% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$15000.0 in 2022, then slumped by 92846.67% to -$13.9 million in 2023, then surged by 147.87% to $6.7 million in 2024, then slipped by 1.65% to $6.6 million in 2025, then sank by 230.09% to -$8.5 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$8.5 million (Q1 2026), $6.6 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Genelux 129.36 Mn 129.36 Mn - -8.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.54 Mn
Mar 31, 2026 -8.54 Mn
Dec 31, 2025 6.56 Mn
Dec 31, 2025 6.56 Mn
Sep 30, 2025 4.72 Mn
Sep 30, 2025 4.72 Mn
Jun 30, 2025 -2.65 Mn
Jun 30, 2025 -2.65 Mn
Mar 31, 2025 3.51 Mn
Mar 31, 2025 3.51 Mn
Dec 31, 2024 6.67 Mn
Dec 31, 2024 6.67 Mn
Sep 30, 2024 3.99 Mn
Sep 30, 2024 3.99 Mn
Jun 30, 2024 -17.11 Mn
Jun 30, 2024 -17.11 Mn
Mar 31, 2024 -1.69 Mn
Mar 31, 2024 -1.69 Mn
Dec 31, 2023 -13.94 Mn
Dec 31, 2023 -13.94 Mn